nodes	percent_of_prediction	percent_of_DWPC	metapath
Zafirlukast—ABCG2—Vandetanib—thyroid cancer	0.208	0.264	CbGbCtD
Zafirlukast—ABCG2—Sorafenib—thyroid cancer	0.125	0.159	CbGbCtD
Zafirlukast—ABCG2—Doxorubicin—thyroid cancer	0.0761	0.0966	CbGbCtD
Zafirlukast—CYP2C8—Sorafenib—thyroid cancer	0.0668	0.0848	CbGbCtD
Zafirlukast—CYP2C19—Sorafenib—thyroid cancer	0.056	0.0711	CbGbCtD
Zafirlukast—CYP1A2—Sorafenib—thyroid cancer	0.0517	0.0656	CbGbCtD
Zafirlukast—CYP2C9—Sorafenib—thyroid cancer	0.0466	0.0592	CbGbCtD
Zafirlukast—CYP3A4—Vandetanib—thyroid cancer	0.0449	0.0571	CbGbCtD
Zafirlukast—CYP2D6—Sorafenib—thyroid cancer	0.0426	0.0541	CbGbCtD
Zafirlukast—CYP3A4—Sorafenib—thyroid cancer	0.0271	0.0344	CbGbCtD
Zafirlukast—CYP2D6—Doxorubicin—thyroid cancer	0.0259	0.0328	CbGbCtD
Zafirlukast—CYP3A4—Doxorubicin—thyroid cancer	0.0164	0.0209	CbGbCtD
Zafirlukast—Leukocytoclastic vasculitis—Sorafenib—thyroid cancer	0.00565	0.0386	CcSEcCtD
Zafirlukast—Haemoptysis—Vandetanib—thyroid cancer	0.00555	0.0379	CcSEcCtD
Zafirlukast—Oropharyngeal discomfort—Sorafenib—thyroid cancer	0.00381	0.0261	CcSEcCtD
Zafirlukast—Dermatitis bullous—Vandetanib—thyroid cancer	0.00312	0.0213	CcSEcCtD
Zafirlukast—Influenza like illness—Sorafenib—thyroid cancer	0.00269	0.0184	CcSEcCtD
Zafirlukast—Neuropathy—Sorafenib—thyroid cancer	0.0026	0.0178	CcSEcCtD
Zafirlukast—Neutropenia—Vandetanib—thyroid cancer	0.00241	0.0165	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Sorafenib—thyroid cancer	0.0023	0.0157	CcSEcCtD
Zafirlukast—Hepatic failure—Sorafenib—thyroid cancer	0.00224	0.0153	CcSEcCtD
Zafirlukast—Sinusitis—Vandetanib—thyroid cancer	0.00215	0.0147	CcSEcCtD
Zafirlukast—Haemoglobin—Vandetanib—thyroid cancer	0.00207	0.0142	CcSEcCtD
Zafirlukast—Haemorrhage—Vandetanib—thyroid cancer	0.00206	0.0141	CcSEcCtD
Zafirlukast—Abdominal discomfort—Sorafenib—thyroid cancer	0.00167	0.0114	CcSEcCtD
Zafirlukast—Neutropenia—Sorafenib—thyroid cancer	0.00162	0.0111	CcSEcCtD
Zafirlukast—Arthralgia—Vandetanib—thyroid cancer	0.00153	0.0105	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00152	0.0104	CcSEcCtD
Zafirlukast—Jaundice—Sorafenib—thyroid cancer	0.00151	0.0103	CcSEcCtD
Zafirlukast—Haematemesis—Epirubicin—thyroid cancer	0.00147	0.0101	CcSEcCtD
Zafirlukast—Oedema—Vandetanib—thyroid cancer	0.00146	0.01	CcSEcCtD
Zafirlukast—Infection—Vandetanib—thyroid cancer	0.00146	0.00996	CcSEcCtD
Zafirlukast—Thrombocytopenia—Vandetanib—thyroid cancer	0.00143	0.00981	CcSEcCtD
Zafirlukast—Blister—Epirubicin—thyroid cancer	0.00142	0.00971	CcSEcCtD
Zafirlukast—Haemoglobin—Sorafenib—thyroid cancer	0.0014	0.00956	CcSEcCtD
Zafirlukast—Haemorrhage—Sorafenib—thyroid cancer	0.00139	0.00951	CcSEcCtD
Zafirlukast—Haemoptysis—Epirubicin—thyroid cancer	0.00138	0.00946	CcSEcCtD
Zafirlukast—Haematemesis—Doxorubicin—thyroid cancer	0.00136	0.00933	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00133	0.00913	CcSEcCtD
Zafirlukast—Insomnia—Vandetanib—thyroid cancer	0.00132	0.00906	CcSEcCtD
Zafirlukast—Blister—Doxorubicin—thyroid cancer	0.00131	0.00899	CcSEcCtD
Zafirlukast—Dyspepsia—Vandetanib—thyroid cancer	0.00129	0.00882	CcSEcCtD
Zafirlukast—Haemoptysis—Doxorubicin—thyroid cancer	0.00128	0.00875	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00126	0.00865	CcSEcCtD
Zafirlukast—Fatigue—Vandetanib—thyroid cancer	0.00126	0.00864	CcSEcCtD
Zafirlukast—Pain—Vandetanib—thyroid cancer	0.00125	0.00857	CcSEcCtD
Zafirlukast—Blood disorder—Epirubicin—thyroid cancer	0.00123	0.00838	CcSEcCtD
Zafirlukast—Liver injury—Epirubicin—thyroid cancer	0.00122	0.00832	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0012	0.00819	CcSEcCtD
Zafirlukast—Abdominal pain—Vandetanib—thyroid cancer	0.00116	0.00792	CcSEcCtD
Zafirlukast—Body temperature increased—Vandetanib—thyroid cancer	0.00116	0.00792	CcSEcCtD
Zafirlukast—Blood disorder—Doxorubicin—thyroid cancer	0.00113	0.00776	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Epirubicin—thyroid cancer	0.00113	0.00775	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Epirubicin—thyroid cancer	0.00113	0.0077	CcSEcCtD
Zafirlukast—Liver injury—Doxorubicin—thyroid cancer	0.00113	0.0077	CcSEcCtD
Zafirlukast—Angioedema—Sorafenib—thyroid cancer	0.00111	0.00757	CcSEcCtD
Zafirlukast—Asthenia—Vandetanib—thyroid cancer	0.00105	0.00719	CcSEcCtD
Zafirlukast—Rectal haemorrhage—Doxorubicin—thyroid cancer	0.00105	0.00717	CcSEcCtD
Zafirlukast—Hyperbilirubinaemia—Doxorubicin—thyroid cancer	0.00104	0.00712	CcSEcCtD
Zafirlukast—Pruritus—Vandetanib—thyroid cancer	0.00104	0.00709	CcSEcCtD
Zafirlukast—Myalgia—Sorafenib—thyroid cancer	0.00103	0.00705	CcSEcCtD
Zafirlukast—Arthralgia—Sorafenib—thyroid cancer	0.00103	0.00705	CcSEcCtD
Zafirlukast—Diarrhoea—Vandetanib—thyroid cancer	0.001	0.00686	CcSEcCtD
Zafirlukast—Influenza like illness—Epirubicin—thyroid cancer	0.000994	0.0068	CcSEcCtD
Zafirlukast—Infection—Sorafenib—thyroid cancer	0.000982	0.00672	CcSEcCtD
Zafirlukast—Dizziness—Vandetanib—thyroid cancer	0.000969	0.00663	CcSEcCtD
Zafirlukast—Thrombocytopenia—Sorafenib—thyroid cancer	0.000967	0.00662	CcSEcCtD
Zafirlukast—Neuropathy—Epirubicin—thyroid cancer	0.000961	0.00657	CcSEcCtD
Zafirlukast—Vomiting—Vandetanib—thyroid cancer	0.000931	0.00637	CcSEcCtD
Zafirlukast—Rash—Vandetanib—thyroid cancer	0.000924	0.00632	CcSEcCtD
Zafirlukast—Dermatitis—Vandetanib—thyroid cancer	0.000923	0.00631	CcSEcCtD
Zafirlukast—Influenza like illness—Doxorubicin—thyroid cancer	0.00092	0.00629	CcSEcCtD
Zafirlukast—Headache—Vandetanib—thyroid cancer	0.000918	0.00628	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.0009	0.00616	CcSEcCtD
Zafirlukast—Neuropathy—Doxorubicin—thyroid cancer	0.000889	0.00608	CcSEcCtD
Zafirlukast—Nausea—Vandetanib—thyroid cancer	0.00087	0.00595	CcSEcCtD
Zafirlukast—Dyspepsia—Sorafenib—thyroid cancer	0.00087	0.00595	CcSEcCtD
Zafirlukast—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000853	0.00584	CcSEcCtD
Zafirlukast—Fatigue—Sorafenib—thyroid cancer	0.000852	0.00583	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00085	0.00582	CcSEcCtD
Zafirlukast—Pain—Sorafenib—thyroid cancer	0.000845	0.00578	CcSEcCtD
Zafirlukast—Hepatic failure—Epirubicin—thyroid cancer	0.000827	0.00566	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000808	0.00553	CcSEcCtD
Zafirlukast—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000787	0.00538	CcSEcCtD
Zafirlukast—Urticaria—Sorafenib—thyroid cancer	0.000785	0.00537	CcSEcCtD
Zafirlukast—Abdominal pain—Sorafenib—thyroid cancer	0.000781	0.00534	CcSEcCtD
Zafirlukast—Body temperature increased—Sorafenib—thyroid cancer	0.000781	0.00534	CcSEcCtD
Zafirlukast—Dermatitis bullous—Epirubicin—thyroid cancer	0.000777	0.00532	CcSEcCtD
Zafirlukast—Hepatic failure—Doxorubicin—thyroid cancer	0.000765	0.00523	CcSEcCtD
Zafirlukast—Hypersensitivity—Sorafenib—thyroid cancer	0.000728	0.00498	CcSEcCtD
Zafirlukast—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000719	0.00492	CcSEcCtD
Zafirlukast—Asthenia—Sorafenib—thyroid cancer	0.000709	0.00485	CcSEcCtD
Zafirlukast—Pruritus—Sorafenib—thyroid cancer	0.000699	0.00478	CcSEcCtD
Zafirlukast—Liver function test abnormal—Epirubicin—thyroid cancer	0.000686	0.00469	CcSEcCtD
Zafirlukast—Diarrhoea—Sorafenib—thyroid cancer	0.000676	0.00463	CcSEcCtD
Zafirlukast—Dizziness—Sorafenib—thyroid cancer	0.000653	0.00447	CcSEcCtD
Zafirlukast—Eosinophilia—Epirubicin—thyroid cancer	0.000636	0.00435	CcSEcCtD
Zafirlukast—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000635	0.00434	CcSEcCtD
Zafirlukast—Vomiting—Sorafenib—thyroid cancer	0.000628	0.0043	CcSEcCtD
Zafirlukast—Rash—Sorafenib—thyroid cancer	0.000623	0.00426	CcSEcCtD
Zafirlukast—Dermatitis—Sorafenib—thyroid cancer	0.000622	0.00426	CcSEcCtD
Zafirlukast—Headache—Sorafenib—thyroid cancer	0.000619	0.00423	CcSEcCtD
Zafirlukast—Neutropenia—Epirubicin—thyroid cancer	0.0006	0.00411	CcSEcCtD
Zafirlukast—Eosinophilia—Doxorubicin—thyroid cancer	0.000588	0.00402	CcSEcCtD
Zafirlukast—Nausea—Sorafenib—thyroid cancer	0.000587	0.00402	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000561	0.00384	CcSEcCtD
Zafirlukast—Jaundice—Epirubicin—thyroid cancer	0.000558	0.00382	CcSEcCtD
Zafirlukast—Neutropenia—Doxorubicin—thyroid cancer	0.000556	0.0038	CcSEcCtD
Zafirlukast—Sinusitis—Epirubicin—thyroid cancer	0.000537	0.00367	CcSEcCtD
Zafirlukast—Agranulocytosis—Epirubicin—thyroid cancer	0.000534	0.00366	CcSEcCtD
Zafirlukast—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000519	0.00355	CcSEcCtD
Zafirlukast—Haemoglobin—Epirubicin—thyroid cancer	0.000517	0.00353	CcSEcCtD
Zafirlukast—Jaundice—Doxorubicin—thyroid cancer	0.000516	0.00353	CcSEcCtD
Zafirlukast—Haemorrhage—Epirubicin—thyroid cancer	0.000514	0.00352	CcSEcCtD
Zafirlukast—Hepatitis—Epirubicin—thyroid cancer	0.000514	0.00352	CcSEcCtD
Zafirlukast—Hypoaesthesia—Epirubicin—thyroid cancer	0.000511	0.0035	CcSEcCtD
Zafirlukast—Sinusitis—Doxorubicin—thyroid cancer	0.000497	0.0034	CcSEcCtD
Zafirlukast—Agranulocytosis—Doxorubicin—thyroid cancer	0.000494	0.00338	CcSEcCtD
Zafirlukast—Haemoglobin—Doxorubicin—thyroid cancer	0.000478	0.00327	CcSEcCtD
Zafirlukast—Haemorrhage—Doxorubicin—thyroid cancer	0.000476	0.00325	CcSEcCtD
Zafirlukast—Hepatitis—Doxorubicin—thyroid cancer	0.000476	0.00325	CcSEcCtD
Zafirlukast—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000473	0.00324	CcSEcCtD
Zafirlukast—Back pain—Epirubicin—thyroid cancer	0.000433	0.00296	CcSEcCtD
Zafirlukast—Ill-defined disorder—Epirubicin—thyroid cancer	0.000415	0.00284	CcSEcCtD
Zafirlukast—Malaise—Epirubicin—thyroid cancer	0.000404	0.00276	CcSEcCtD
Zafirlukast—Back pain—Doxorubicin—thyroid cancer	0.0004	0.00274	CcSEcCtD
Zafirlukast—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000384	0.00263	CcSEcCtD
Zafirlukast—Myalgia—Epirubicin—thyroid cancer	0.000381	0.00261	CcSEcCtD
Zafirlukast—Arthralgia—Epirubicin—thyroid cancer	0.000381	0.00261	CcSEcCtD
Zafirlukast—Discomfort—Epirubicin—thyroid cancer	0.000376	0.00257	CcSEcCtD
Zafirlukast—Malaise—Doxorubicin—thyroid cancer	0.000373	0.00255	CcSEcCtD
Zafirlukast—Oedema—Epirubicin—thyroid cancer	0.000365	0.0025	CcSEcCtD
Zafirlukast—Infection—Epirubicin—thyroid cancer	0.000363	0.00248	CcSEcCtD
Zafirlukast—Thrombocytopenia—Epirubicin—thyroid cancer	0.000358	0.00245	CcSEcCtD
Zafirlukast—Myalgia—Doxorubicin—thyroid cancer	0.000352	0.00241	CcSEcCtD
Zafirlukast—Arthralgia—Doxorubicin—thyroid cancer	0.000352	0.00241	CcSEcCtD
Zafirlukast—Discomfort—Doxorubicin—thyroid cancer	0.000348	0.00238	CcSEcCtD
Zafirlukast—Oedema—Doxorubicin—thyroid cancer	0.000338	0.00231	CcSEcCtD
Zafirlukast—Infection—Doxorubicin—thyroid cancer	0.000336	0.0023	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000333	0.00228	CcSEcCtD
Zafirlukast—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000331	0.00226	CcSEcCtD
Zafirlukast—Insomnia—Epirubicin—thyroid cancer	0.00033	0.00226	CcSEcCtD
Zafirlukast—Dyspepsia—Epirubicin—thyroid cancer	0.000321	0.0022	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—TSHR—thyroid cancer	0.000318	0.00481	CbGpPWpGaD
Zafirlukast—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000315	0.00216	CcSEcCtD
Zafirlukast—Fatigue—Epirubicin—thyroid cancer	0.000315	0.00215	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000313	0.00473	CbGpPWpGaD
Zafirlukast—Pain—Epirubicin—thyroid cancer	0.000312	0.00214	CcSEcCtD
Zafirlukast—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000308	0.00211	CcSEcCtD
Zafirlukast—Insomnia—Doxorubicin—thyroid cancer	0.000306	0.00209	CcSEcCtD
Zafirlukast—Feeling abnormal—Epirubicin—thyroid cancer	0.000301	0.00206	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000299	0.00204	CcSEcCtD
Zafirlukast—Dyspepsia—Doxorubicin—thyroid cancer	0.000297	0.00203	CcSEcCtD
Zafirlukast—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	0.000293	0.00443	CbGpPWpGaD
Zafirlukast—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000292	0.002	CcSEcCtD
Zafirlukast—Fatigue—Doxorubicin—thyroid cancer	0.000291	0.00199	CcSEcCtD
Zafirlukast—Urticaria—Epirubicin—thyroid cancer	0.00029	0.00198	CcSEcCtD
Zafirlukast—Pain—Doxorubicin—thyroid cancer	0.000289	0.00198	CcSEcCtD
Zafirlukast—Body temperature increased—Epirubicin—thyroid cancer	0.000289	0.00197	CcSEcCtD
Zafirlukast—Abdominal pain—Epirubicin—thyroid cancer	0.000289	0.00197	CcSEcCtD
Zafirlukast—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000289	0.00436	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CALCB—thyroid cancer	0.000281	0.00425	CbGpPWpGaD
Zafirlukast—Feeling abnormal—Doxorubicin—thyroid cancer	0.000278	0.0019	CcSEcCtD
Zafirlukast—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000276	0.00189	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR downstream signaling—SST—thyroid cancer	0.000272	0.00412	CbGpPWpGaD
Zafirlukast—CYP2E1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000271	0.00409	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—PTCH1—thyroid cancer	0.00027	0.00409	CbGpPWpGaD
Zafirlukast—Hypersensitivity—Epirubicin—thyroid cancer	0.000269	0.00184	CcSEcCtD
Zafirlukast—Urticaria—Doxorubicin—thyroid cancer	0.000268	0.00184	CcSEcCtD
Zafirlukast—Abdominal pain—Doxorubicin—thyroid cancer	0.000267	0.00183	CcSEcCtD
Zafirlukast—Body temperature increased—Doxorubicin—thyroid cancer	0.000267	0.00183	CcSEcCtD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.000267	0.00404	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TRIM33—thyroid cancer	0.000266	0.00403	CbGpPWpGaD
Zafirlukast—Asthenia—Epirubicin—thyroid cancer	0.000262	0.00179	CcSEcCtD
Zafirlukast—CYSLTR2—GPCR downstream signaling—CALCA—thyroid cancer	0.000262	0.00396	CbGpPWpGaD
Zafirlukast—Pruritus—Epirubicin—thyroid cancer	0.000258	0.00177	CcSEcCtD
Zafirlukast—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000258	0.00389	CbGpPWpGaD
Zafirlukast—PTGS1—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000257	0.00388	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TCF7L1—thyroid cancer	0.000256	0.00388	CbGpPWpGaD
Zafirlukast—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000256	0.00387	CbGpPWpGaD
Zafirlukast—Diarrhoea—Epirubicin—thyroid cancer	0.00025	0.00171	CcSEcCtD
Zafirlukast—Hypersensitivity—Doxorubicin—thyroid cancer	0.000249	0.0017	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—SST—thyroid cancer	0.000247	0.00374	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—TSHR—thyroid cancer	0.000243	0.00367	CbGpPWpGaD
Zafirlukast—Asthenia—Doxorubicin—thyroid cancer	0.000242	0.00166	CcSEcCtD
Zafirlukast—Dizziness—Epirubicin—thyroid cancer	0.000241	0.00165	CcSEcCtD
Zafirlukast—Pruritus—Doxorubicin—thyroid cancer	0.000239	0.00164	CcSEcCtD
Zafirlukast—CYSLTR2—Signaling by GPCR—CALCA—thyroid cancer	0.000238	0.0036	CbGpPWpGaD
Zafirlukast—CYP2D6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000237	0.00358	CbGpPWpGaD
Zafirlukast—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000235	0.00355	CbGpPWpGaD
Zafirlukast—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000234	0.00354	CbGpPWpGaD
Zafirlukast—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000234	0.00353	CbGpPWpGaD
Zafirlukast—Vomiting—Epirubicin—thyroid cancer	0.000232	0.00159	CcSEcCtD
Zafirlukast—Diarrhoea—Doxorubicin—thyroid cancer	0.000231	0.00158	CcSEcCtD
Zafirlukast—Rash—Epirubicin—thyroid cancer	0.00023	0.00158	CcSEcCtD
Zafirlukast—Dermatitis—Epirubicin—thyroid cancer	0.00023	0.00157	CcSEcCtD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.00023	0.00347	CbGpPWpGaD
Zafirlukast—Headache—Epirubicin—thyroid cancer	0.000229	0.00157	CcSEcCtD
Zafirlukast—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000226	0.00342	CbGpPWpGaD
Zafirlukast—Dizziness—Doxorubicin—thyroid cancer	0.000223	0.00153	CcSEcCtD
Zafirlukast—ABCG2—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000222	0.00335	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—TSHR—thyroid cancer	0.00022	0.00333	CbGpPWpGaD
Zafirlukast—Nausea—Epirubicin—thyroid cancer	0.000217	0.00148	CcSEcCtD
Zafirlukast—CYSLTR1—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000217	0.00328	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—CDK1—thyroid cancer	0.000215	0.00326	CbGpPWpGaD
Zafirlukast—Vomiting—Doxorubicin—thyroid cancer	0.000215	0.00147	CcSEcCtD
Zafirlukast—Rash—Doxorubicin—thyroid cancer	0.000213	0.00146	CcSEcCtD
Zafirlukast—Dermatitis—Doxorubicin—thyroid cancer	0.000213	0.00146	CcSEcCtD
Zafirlukast—Headache—Doxorubicin—thyroid cancer	0.000212	0.00145	CcSEcCtD
Zafirlukast—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000209	0.00316	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000204	0.00309	CbGpPWpGaD
Zafirlukast—Nausea—Doxorubicin—thyroid cancer	0.000201	0.00137	CcSEcCtD
Zafirlukast—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000201	0.00303	CbGpPWpGaD
Zafirlukast—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.0002	0.00302	CbGpPWpGaD
Zafirlukast—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000195	0.00295	CbGpPWpGaD
Zafirlukast—PTGS1—Biological oxidations—RXRA—thyroid cancer	0.000192	0.00291	CbGpPWpGaD
Zafirlukast—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000192	0.0029	CbGpPWpGaD
Zafirlukast—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00019	0.00288	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—SST—thyroid cancer	0.000189	0.00285	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TSHR—thyroid cancer	0.000188	0.00284	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—PTCH1—thyroid cancer	0.000187	0.00283	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.000185	0.0028	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PRKAR1A—thyroid cancer	0.000185	0.00279	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—CALCA—thyroid cancer	0.000182	0.00275	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TCF7L1—thyroid cancer	0.000178	0.00269	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—MEN1—thyroid cancer	0.000177	0.00267	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—SST—thyroid cancer	0.000171	0.00259	CbGpPWpGaD
Zafirlukast—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000166	0.00251	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CALCA—thyroid cancer	0.000165	0.00249	CbGpPWpGaD
Zafirlukast—PTGS1—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000163	0.00247	CbGpPWpGaD
Zafirlukast—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000163	0.00246	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PTCH1—thyroid cancer	0.00016	0.00241	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000159	0.00241	CbGpPWpGaD
Zafirlukast—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000155	0.00234	CbGpPWpGaD
Zafirlukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000154	0.00233	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—CDK1—thyroid cancer	0.000149	0.00226	CbGpPWpGaD
Zafirlukast—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000148	0.00224	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—MINPP1—thyroid cancer	0.000147	0.00222	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—SST—thyroid cancer	0.000146	0.00221	CbGpPWpGaD
Zafirlukast—CYP2E1—Biological oxidations—RXRA—thyroid cancer	0.000144	0.00217	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—MINPP1—thyroid cancer	0.000141	0.00214	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CALCA—thyroid cancer	0.000141	0.00212	CbGpPWpGaD
Zafirlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000135	0.00205	CbGpPWpGaD
Zafirlukast—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000135	0.00204	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000132	0.002	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TSHR—thyroid cancer	0.00013	0.00197	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PRKAR1A—thyroid cancer	0.000128	0.00194	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CDK1—thyroid cancer	0.000127	0.00192	CbGpPWpGaD
Zafirlukast—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000126	0.0019	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—NDUFA13—thyroid cancer	0.000125	0.00189	CbGpPWpGaD
Zafirlukast—CYP2C8—Biological oxidations—RXRA—thyroid cancer	0.000124	0.00188	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000123	0.00186	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—MEN1—thyroid cancer	0.000122	0.00185	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—NDUFA13—thyroid cancer	0.00012	0.00182	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000118	0.00178	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—CHST14—thyroid cancer	0.000118	0.00178	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000116	0.00176	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000116	0.00176	CbGpPWpGaD
Zafirlukast—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000115	0.00174	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000114	0.00173	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—CHST14—thyroid cancer	0.000113	0.00171	CbGpPWpGaD
Zafirlukast—CYP2C19—Biological oxidations—RXRA—thyroid cancer	0.000111	0.00168	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PTCH1—thyroid cancer	0.000111	0.00167	CbGpPWpGaD
Zafirlukast—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	0.000108	0.00163	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000107	0.00163	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—MINPP1—thyroid cancer	0.000106	0.0016	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NRG1—thyroid cancer	0.000102	0.00154	CbGpPWpGaD
Zafirlukast—CYP2D6—Biological oxidations—RXRA—thyroid cancer	0.000102	0.00154	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—SST—thyroid cancer	0.000101	0.00153	CbGpPWpGaD
Zafirlukast—CYP2C9—Biological oxidations—RXRA—thyroid cancer	0.000101	0.00153	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CALCA—thyroid cancer	9.74e-05	0.00147	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	9.59e-05	0.00145	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—HPGD—thyroid cancer	9.48e-05	0.00143	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	9.19e-05	0.00139	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TERT—thyroid cancer	9.17e-05	0.00139	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—MINPP1—thyroid cancer	9.13e-05	0.00138	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—HPGD—thyroid cancer	9.11e-05	0.00138	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—NDUFA13—thyroid cancer	8.98e-05	0.00136	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CDK1—thyroid cancer	8.82e-05	0.00133	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HIF1A—thyroid cancer	8.77e-05	0.00133	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.7e-05	0.00132	CbGpPWpGaD
Zafirlukast—CYP1A2—Biological oxidations—RXRA—thyroid cancer	8.64e-05	0.00131	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—CHST14—thyroid cancer	8.44e-05	0.00128	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	8.26e-05	0.00125	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—MINPP1—thyroid cancer	8.15e-05	0.00123	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—NDUFA13—thyroid cancer	7.76e-05	0.00117	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—NRAS—thyroid cancer	7.72e-05	0.00117	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—MINPP1—thyroid cancer	7.49e-05	0.00113	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—MINPP1—thyroid cancer	7.43e-05	0.00112	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.39e-05	0.00112	CbGpPWpGaD
Zafirlukast—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.31e-05	0.00111	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—CHST14—thyroid cancer	7.3e-05	0.0011	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—BRAF—thyroid cancer	7.26e-05	0.0011	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NRG1—thyroid cancer	7.08e-05	0.00107	CbGpPWpGaD
Zafirlukast—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	7.02e-05	0.00106	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—NDUFA13—thyroid cancer	6.93e-05	0.00105	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—HPGD—thyroid cancer	6.81e-05	0.00103	CbGpPWpGaD
Zafirlukast—CYP3A4—Biological oxidations—RXRA—thyroid cancer	6.67e-05	0.00101	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—KRAS—thyroid cancer	6.65e-05	0.00101	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—CHST14—thyroid cancer	6.51e-05	0.000985	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—NDUFA13—thyroid cancer	6.37e-05	0.000963	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TERT—thyroid cancer	6.36e-05	0.000961	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—MINPP1—thyroid cancer	6.35e-05	0.00096	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—NDUFA13—thyroid cancer	6.32e-05	0.000955	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HIF1A—thyroid cancer	6.08e-05	0.000919	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—CHST14—thyroid cancer	5.99e-05	0.000906	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—CHST14—thyroid cancer	5.94e-05	0.000898	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—HPGD—thyroid cancer	5.88e-05	0.000889	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—HRAS—thyroid cancer	5.65e-05	0.000854	CbGpPWpGaD
Zafirlukast—CYSLTR2—GPCR downstream signaling—AKT1—thyroid cancer	5.49e-05	0.000831	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—TPR—thyroid cancer	5.44e-05	0.000823	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—NDUFA13—thyroid cancer	5.4e-05	0.000816	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PRKAR1A—thyroid cancer	5.36e-05	0.00081	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—NRAS—thyroid cancer	5.35e-05	0.00081	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—CCND1—thyroid cancer	5.3e-05	0.000801	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—HPGD—thyroid cancer	5.25e-05	0.000794	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—TPR—thyroid cancer	5.23e-05	0.000791	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PRKAR1A—thyroid cancer	5.15e-05	0.000778	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—PTEN—thyroid cancer	5.11e-05	0.000773	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—CHST14—thyroid cancer	5.08e-05	0.000767	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—BRAF—thyroid cancer	5.03e-05	0.000761	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling by GPCR—AKT1—thyroid cancer	4.99e-05	0.000754	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—MINPP1—thyroid cancer	4.9e-05	0.000741	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—HPGD—thyroid cancer	4.83e-05	0.00073	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—HPGD—thyroid cancer	4.79e-05	0.000724	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.77e-05	0.000721	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.66e-05	0.000705	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—KRAS—thyroid cancer	4.61e-05	0.000697	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—NRAS—thyroid cancer	4.56e-05	0.00069	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.26e-05	0.000644	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—NDUFA13—thyroid cancer	4.17e-05	0.00063	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—HPGD—thyroid cancer	4.09e-05	0.000619	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—SLC5A5—thyroid cancer	4.08e-05	0.000616	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—KRAS—thyroid cancer	3.93e-05	0.000594	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—HRAS—thyroid cancer	3.92e-05	0.000592	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—CHST14—thyroid cancer	3.92e-05	0.000592	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—SLC5A5—thyroid cancer	3.92e-05	0.000592	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—TPR—thyroid cancer	3.91e-05	0.000591	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.88e-05	0.000587	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	3.85e-05	0.000581	CbGpPWpGaD
Zafirlukast—CYSLTR1—GPCR downstream signaling—AKT1—thyroid cancer	3.81e-05	0.000576	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—CCND1—thyroid cancer	3.67e-05	0.000555	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.67e-05	0.000555	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—PTEN—thyroid cancer	3.55e-05	0.000536	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—TP53—thyroid cancer	3.49e-05	0.000528	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling by GPCR—AKT1—thyroid cancer	3.46e-05	0.000523	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—RXRA—thyroid cancer	3.42e-05	0.000518	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—TPR—thyroid cancer	3.38e-05	0.000511	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—HRAS—thyroid cancer	3.34e-05	0.000505	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	3.32e-05	0.000503	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	3.32e-05	0.000502	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—RXRA—thyroid cancer	3.29e-05	0.000497	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.2e-05	0.000484	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—NRAS—thyroid cancer	3.16e-05	0.000478	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—HPGD—thyroid cancer	3.16e-05	0.000477	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—TPR—thyroid cancer	3.02e-05	0.000456	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.01e-05	0.000455	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	2.97e-05	0.000449	CbGpPWpGaD
Zafirlukast—CYSLTR2—Signaling Pathways—AKT1—thyroid cancer	2.95e-05	0.000446	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—SLC5A5—thyroid cancer	2.93e-05	0.000442	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—TPR—thyroid cancer	2.77e-05	0.000419	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—TPR—thyroid cancer	2.75e-05	0.000416	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	2.73e-05	0.000413	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—KRAS—thyroid cancer	2.72e-05	0.000412	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	2.7e-05	0.000409	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.69e-05	0.000407	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—SLC5A5—thyroid cancer	2.53e-05	0.000382	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—RXRA—thyroid cancer	2.46e-05	0.000372	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.45e-05	0.000371	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—TP53—thyroid cancer	2.42e-05	0.000366	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.37e-05	0.000358	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—TPR—thyroid cancer	2.35e-05	0.000355	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—HRAS—thyroid cancer	2.31e-05	0.00035	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	2.31e-05	0.00035	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—SLC5A5—thyroid cancer	2.26e-05	0.000341	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PPARG—thyroid cancer	2.16e-05	0.000327	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—RXRA—thyroid cancer	2.12e-05	0.000321	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.12e-05	0.00032	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.1e-05	0.000317	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PPARG—thyroid cancer	2.08e-05	0.000314	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—SLC5A5—thyroid cancer	2.08e-05	0.000314	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.07e-05	0.000312	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—SLC5A5—thyroid cancer	2.06e-05	0.000311	CbGpPWpGaD
Zafirlukast—CYSLTR1—Signaling Pathways—AKT1—thyroid cancer	2.04e-05	0.000309	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.93e-05	0.000292	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—RXRA—thyroid cancer	1.9e-05	0.000287	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.84e-05	0.000279	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—TPR—thyroid cancer	1.81e-05	0.000274	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.78e-05	0.00027	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—SLC5A5—thyroid cancer	1.76e-05	0.000266	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—RXRA—thyroid cancer	1.74e-05	0.000264	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—RXRA—thyroid cancer	1.73e-05	0.000261	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTGS2—thyroid cancer	1.7e-05	0.000257	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.68e-05	0.000254	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.65e-05	0.000249	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTGS2—thyroid cancer	1.63e-05	0.000247	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PPARG—thyroid cancer	1.55e-05	0.000235	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—PTEN—thyroid cancer	1.48e-05	0.000224	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—RXRA—thyroid cancer	1.48e-05	0.000223	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.44e-05	0.000217	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—PTEN—thyroid cancer	1.42e-05	0.000215	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.36e-05	0.000205	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PPARG—thyroid cancer	1.34e-05	0.000203	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTGS2—thyroid cancer	1.22e-05	0.000185	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PPARG—thyroid cancer	1.2e-05	0.000181	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—RXRA—thyroid cancer	1.14e-05	0.000172	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PPARG—thyroid cancer	1.1e-05	0.000167	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PPARG—thyroid cancer	1.09e-05	0.000165	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—PTEN—thyroid cancer	1.06e-05	0.000161	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTGS2—thyroid cancer	1.06e-05	0.00016	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTGS2—thyroid cancer	9.42e-06	0.000142	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PPARG—thyroid cancer	9.33e-06	0.000141	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—PTEN—thyroid cancer	9.2e-06	0.000139	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTGS2—thyroid cancer	8.66e-06	0.000131	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTGS2—thyroid cancer	8.59e-06	0.00013	CbGpPWpGaD
Zafirlukast—ABCG2—Metabolism—AKT1—thyroid cancer	8.55e-06	0.000129	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—PTEN—thyroid cancer	8.22e-06	0.000124	CbGpPWpGaD
Zafirlukast—PTGS1—Metabolism—AKT1—thyroid cancer	8.21e-06	0.000124	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—PTEN—thyroid cancer	7.56e-06	0.000114	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—PTEN—thyroid cancer	7.49e-06	0.000113	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTGS2—thyroid cancer	7.34e-06	0.000111	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PPARG—thyroid cancer	7.2e-06	0.000109	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—PTEN—thyroid cancer	6.4e-06	9.68e-05	CbGpPWpGaD
Zafirlukast—CYP2E1—Metabolism—AKT1—thyroid cancer	6.14e-06	9.28e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTGS2—thyroid cancer	5.66e-06	8.57e-05	CbGpPWpGaD
Zafirlukast—CYP2C8—Metabolism—AKT1—thyroid cancer	5.3e-06	8.02e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—PTEN—thyroid cancer	4.94e-06	7.47e-05	CbGpPWpGaD
Zafirlukast—CYP2C19—Metabolism—AKT1—thyroid cancer	4.73e-06	7.16e-05	CbGpPWpGaD
Zafirlukast—CYP2D6—Metabolism—AKT1—thyroid cancer	4.35e-06	6.58e-05	CbGpPWpGaD
Zafirlukast—CYP2C9—Metabolism—AKT1—thyroid cancer	4.32e-06	6.53e-05	CbGpPWpGaD
Zafirlukast—CYP1A2—Metabolism—AKT1—thyroid cancer	3.69e-06	5.58e-05	CbGpPWpGaD
Zafirlukast—CYP3A4—Metabolism—AKT1—thyroid cancer	2.85e-06	4.3e-05	CbGpPWpGaD
